Table of Content

1. Introduction
 1.1. Market Definition & Scope
 1.2. Market Ecosystem
 1.3. Currency & Limitations
 1.4. Key Stakeholders

2. Research Methodology
  2.1. Research Approach
  2.2. Process of Data Collection and Validation
    2.2.1. Secondary Research
    2.2.2. Primary Research/Interviews with Key Opinion Leaders From The Industry
  2.3. Market Sizing & Forecasting
    2.3.1. Market Size Estimation Approach
    2.3.2. Growth Forecast Approach
  2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
  4.1. Overview
  4.2. Factors Affecting Market Growth
    4.2.1. Drivers
      4.2.1.1. Increasing Government Focus on Immunization Programs
      4.2.1.2. Technological Advancements in Vaccine Administration
    4.2.2. Restraints
      4.2.2.1. High Costs of Vaccine Development
      4.2.2.2. Long Timelines of Vaccine Manufacturing
    4.2.3. Opportunities
      4.2.3.1. Growing Focus on Therapeutic Vaccines
      4.2.3.2. Increasing Use of Adjuvants in Vaccines
      4.2.3.3. Growth Prospects in Emerging Markets
    4.2.4. Challenges
      4.2.4.1. Product Recalls
      4.2.4.2. Inadequate Access to Vaccines
    4.2.5. Key Trends
      4.2.5.1. Personalized Vaccines and Vaccinomics
      4.2.5.2. Media and Public Awareness Regarding Immunization
  4.3. Regulatory Analysis
  4.4. Pricing Analysis
  4.5. Porter’s Five Forces Analysis
    4.5.1. Bargaining Power of Buyers
    4.5.2. Bargaining Power of Suppliers
    4.5.3. Threat of Substitutes
    4.5.4. Threat of New Entrants
    4.5.5. Degree of Competition
  4.6. Pipeline Analysis

5. Viral Vaccines Market Assessment?by Form
  5.1. Overview
  5.2. Liquid Viral Vaccines
  5.3. Lyophilized Viral Vaccines

6. Viral Vaccines Market?by Vaccine Type
  6.1. Overview
  6.2. mRNA Vaccines
  6.3. Subunit & Conjugate Vaccines
  6.4. Live-attenuated Vaccines
  6.5. Inactivated Vaccines
  6.6. Viral Vector Vaccines
  6.7. Combination Vaccines

7. Viral Vaccines Market Assessment?by Route of Administration
  7.1. Overview
  7.2. Intramuscular (IM)
  7.3. Subcutaneous (SC)
  7.4. Oral
  7.5. Other Routes of Administration

8. Viral Vaccines Market Assessment?by Approach
  8.1. Overview
  8.2. Preventive Vaccines
  8.3. Therapeutic Vaccines

9. Viral Vaccines Market Assessment?by Indication
  9.1. Overview
  9.2. Influenza
  9.3. Human Papillomavirus (HPV)
  9.4. Rotavirus
  9.5. Poliomyelitis (Polio)
  9.6. Hepatitis
  9.7. Cancer
  9.8. Other Indications

10. Viral Vaccines Market Assessment?by Packaging
  10.1. Overview
  10.2. Vials
  10.3. Prefilled Syringes

11. Coronavirus Disease
  11.1. COVID-19: Overview
  11.2. Coronavirus Prevalence
  11.3. COVID-19 Market Assessment

12. Viral Vaccines Market Assessment?by Geography
  12.1. Overview
  12.2. North America
    12.2.1. U.S.
    12.2.2. Canada
  12.3. Europe
    12.3.1. Germany
    12.3.2. U.K.
    12.3.3. France
    12.3.4. Italy
    12.3.5. Spain
    12.3.6. Switzerland
    12.3.7. Ireland
    12.3.8. Denmark
    12.3.9. Belgium
    12.3.10. Rest of Europe
  12.4. Asia-Pacific
    12.4.1. Japan
    12.4.2. China
    12.4.3. India
    12.4.4. South Korea
    12.4.5. Rest of Asia-Pacific
  12.5. Latin America
    12.5.1. Brazil
    12.5.2. Mexico
    12.5.3. Rest of Latin America
  12.6. Middle East & Africa

13. Competitive Landscape
  13.1. Introduction
  13.2. Key Growth Strategies
  13.3. Competitive Benchmarking
  13.4. Competitive Dashboard
    13.4.1. Industry Leaders
    13.4.2. Market Differentiators
    13.4.3. Vanguards
    13.4.4. Emerging Companies
  13.5. Market Share Analysis

14. Company Profiles
  14.1. Pfizer Inc.
  14.2. Glaxo Smith Kline plc
  14.3. AstraZeneca plc
  14.4. CSL Limited
  14.5. Merck & Co., Inc.
  14.6. Moderna, Inc.
  14.7. Johnson & Johnson
  14.8. Emergent Biosolutions Inc.
  14.9. Bharat Biotech Ltd.
  14.10. Sinovac Biotech Ltd.
  14.11. Sanofi
  14.12. Serum Institute of India Pvt. Ltd.
  14.13. Dynavax Technologies Corporation
  14.14. Valneva SE

15. Appendix
  15.1. Available Customization
  15.2. Related Reports



List of Figures

Figure 1?? ?Research Process?
Figure 2?? ?Secondary Sources Referenced for this Study?
Figure 3?? ?Primary Research Techniques?
Figure 4?? ?Key Executives Interviewed?
Figure 5?? ?Breakdown of Primary Interviews (Supply-Side & Demand-Side)?
Figure 6?? ?Market Sizing and Growth Forecast Approaches?
Figure 7?? ?Global Viral Vaccines Market, by Indication, 2024 Vs.2031 (USD Million)?
Figure 8?? ?Global Viral Vaccines Market, by Form, 2024 Vs. 2031 (USD Million)?
Figure 9?? ?Global Viral Vaccines Market, by Vaccine Type, 2024 Vs. 2031 (USD Million)?
Figure 10?? ?Global Viral Vaccines Market, by Route of Administration, 2024 Vs. 2031 (USD Million)?
Figure 11?? ?Global Viral Vaccines Market, by Approach, 2024 Vs. 2031 (USD Million)?
Figure 12?? ?Global Viral Vaccines Market, by Packaging, 2024 Vs. 2031 (USD Million)?
Figure 13?? ?Global Viral Vaccines Market, by Geography?
Figure 14?? ?Impact Analysis of Market Dynamics?
Figure 15?? ?Porter’s Five Forces Analysis?
Figure 16?? ?Global Viral Vaccines Market, by Form, 2024 Vs. 2031 (USD Million)?
Figure 17?? ?Global Viral Vaccines Market, by Vaccine Type, 2024 Vs. 2031 (USD Million)?
Figure 18?? ?Global Viral Vaccines Market, by Route of Administration, 2024 Vs. 2031 (USD Million)?
Figure 19?? ?Global Viral Vaccines Market, by Approach, 2024 VS. 2031 (USD Million)?
Figure 20?? ?Global Viral Vaccines Market, by Indication, 2024 VS. 2031 (USD Million)?
Figure 21?? ?Global Viral Vaccines Market, by Packaging, 2024 VS. 2031 (USD Million)?
Figure 22?? ?Global Viral Vaccines Market, by GEOGRAPHY, 2024 VS. 2031 (USD Million)?
Figure 23?? ?North America: Viral Vaccines Market Snapshot?
Figure 24?? ?Europe: Viral Vaccines Market Snapshot?
Figure 25?? ?Asia-Pacific: Viral Vaccines Market Snapshot?
Figure 26?? ?Number of Cases Reported for Dengue, 2019-2023?
Figure 27?? ?Latin America: Viral Vaccines Market Snapshot?
Figure 28?? ?Saudi Arabia Viral Vaccination Coverage (2023)?
Figure 29?? ?Key Growth Strategies Adopted By Leading Players, 2021-2024?
Figure 30?? ?Viral Vaccines Market: Competitive Benchmarking (Based On Indications)?
Figure 31?? ?Viral Vaccines Market: Competitive Benchmarking (BASED ON Region)?
Figure 32?? ?Competitive Dashboard: Viral Vaccines Market?
Figure 33?? ?Market Share Analysis: Viral Vaccines Market (with Covid-19 Vaccines), 2023?
Figure 34?? ?Market Share Analysis: Viral Vaccines Market (Without Covid-19 Vaccines), 2023?
Figure 35?? ?Pfizer Inc.: Financial Snapshot (2023)?
Figure 36?? ?Glaxo Smith Kline Plc: Financial Overview (2023)?
Figure 37?? ?AstraZeneca Plc: Financial Overview (2023)?
Figure 38?? ?CSL LIMITED: Financial Overview (2024)?
Figure 39?? ?Merck & Co., Inc.: Financial Overview (2023)?
Figure 40?? ?Moderna, Inc.: Financial Snapshot (2023)?
Figure 41?? ?Johnson & Johnson: Financial Snapshot (2023)?
Figure 42?? ?Emergent Biosolutions Inc.: Financial Snapshot (2023)?
Figure 43?? ?Sinovac Biotech Ltd.: Financial Overview (2023)?
Figure 44?? ?Sanofi: Financial Overview (2023)?
Figure 45?? ?Dynavax Technologies Corporation: Financial Snapshot (2023)?
Figure 46?? ?Valneva SE: Financial Snapshot (2023)?